ARCHIVES

Study Finds That CTC Was Used Correctly In Medicare Patients

This article is from The Cancer Letter archive.

Vol. 36 No. 4 | April 26, 2013

Download PDF Visit The Full Archive

Related Articles

Coulter And Venture Capital Firm Form Company To Develop B1 Antibody For NHL

April 28, 1995

NCCTG Plans To Conduct Phase II Study Of Brostallicin Plus Cisplatin For mTNBC

April 30, 2010

The Cancer Letter Offers FAX Delivery

January 7, 1994

Funding Opportunities (8-page issue).

April 25, 2003

Also David Schwartz of Duke University to head NIEHS.

October 29, 2004

DCE Publishes Lister of Resources Available To Scientific Community

November 9, 1984